Covance, Inc. (NYSE:CVD)

CAPS Rating: 4 out of 5

A drug development services company providing a range of early stage and late stage product development services on a worldwide basis primarily to the pharmaceutical, biotechnology and medical device industries.

Featured Broker Partners


Advertisement